These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16996834)

  • 1. Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results.
    Beeres SL; Bax JJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    Am Heart J; 2006 Oct; 152(4):684.e11-6. PubMed ID: 16996834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.
    Beeres SL; Bax JJ; Dibbets P; Stokkel MP; Zeppenfeld K; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    J Nucl Med; 2006 Apr; 47(4):574-80. PubMed ID: 16595489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.
    Beeres SL; Bax JJ; Kaandorp TA; Zeppenfeld K; Lamb HJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; de Roos A; van der Wall EE; Schalij MJ; Atsma DE
    Am J Cardiol; 2006 May; 97(9):1326-31. PubMed ID: 16635605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease.
    Beeres SL; Zeppenfeld K; Bax JJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; van der Wall EE; Atsma DE; Schalij MJ
    Heart Rhythm; 2007 Mar; 4(3):257-65. PubMed ID: 17341383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of Life.
    Mann I; Rodrigo SF; van Ramshorst J; Beeres SL; Dibbets-Schneider P; de Roos A; Wolterbeek R; Zwaginga JJ; Fibbe WE; Bax JJ; Schalij MJ; Atsma DE
    Circ Cardiovasc Interv; 2015 Aug; 8(8):. PubMed ID: 26259770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison.
    Rodrigo SF; van Ramshorst J; Beeres SL; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Schalij MJ; Bax JJ; Atsma DE
    Am Heart J; 2012 Nov; 164(5):771-8. PubMed ID: 23137509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
    van Ramshorst J; Bax JJ; Beeres SL; Dibbets-Schneider P; Roes SD; Stokkel MP; de Roos A; Fibbe WE; Zwaginga JJ; Boersma E; Schalij MJ; Atsma DE
    JAMA; 2009 May; 301(19):1997-2004. PubMed ID: 19454638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results.
    Pompilio G; Steinhoff G; Liebold A; Pesce M; Alamanni F; Capogrossi MC; Biglioli P
    Thorac Cardiovasc Surg; 2008 Mar; 56(2):71-6. PubMed ID: 18278680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia.
    Rodrigo SF; van Ramshorst J; Mann I; Leong DP; Cannegieter SC; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Bax JJ; Schalij MJ; Beeres SL; Atsma DE
    Int J Cardiol; 2014 Aug; 175(3):539-44. PubMed ID: 25023791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction.
    Beeres SL; Bax JJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    Am J Cardiol; 2007 Oct; 100(7):1094-8. PubMed ID: 17884369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramyocardial bone marrow cell transplantation and the progression of coronary atherosclerosis in patients with chronic myocardial ischemia.
    Beeres SL; Bax JJ; Roes SD; Lamb HJ; Fibbe WE; De Roos A; Van Der Wall EE; Schalij MJ; Atsma DE
    Acute Card Care; 2007; 9(4):243-51. PubMed ID: 17926149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina.
    Briguori C; Reimers B; Sarais C; Napodano M; Pascotto P; Azzarello G; Bregni M; Porcellini A; Vinante O; Zanco P; Peschle C; Condorelli G; Colombo A
    Am Heart J; 2006 Mar; 151(3):674-80. PubMed ID: 16504630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Transendocardial Delivery of Bone Marrow-Derived CD133
    Wojakowski W; Jadczyk T; Michalewska-Włudarczyk A; Parma Z; Markiewicz M; Rychlik W; Kostkiewicz M; Gruszczyńska K; Błach A; Dzier Zak-Mietła M; Wańha W; Ciosek J; Ochała B; Rzeszutko Ł; Cybulski W; Partyka Ł; Zasada W; Włudarczyk W; Dworowy S; Kuczmik W; Smolka G; Pawłowski T; Ochała A; Tendera M
    Circ Res; 2017 Feb; 120(4):670-680. PubMed ID: 27903568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
    Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Mesquita CT; Rossi MI; Carvalho AC; Dutra HS; Dohmann HJ; Silva GV; Belém L; Vivacqua R; Rangel FO; Esporcatte R; Geng YJ; Vaughn WK; Assad JA; Mesquita ET; Willerson JT
    Circulation; 2003 May; 107(18):2294-302. PubMed ID: 12707230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133
    Bassetti B; Carbucicchio C; Catto V; Gambini E; Rurali E; Bestetti A; Gaipa G; Belotti D; Celeste F; Parma M; Righetti S; Biava L; Arosio M; Bonomi A; Agostoni P; Scacciatella P; Achilli F; Pompilio G
    Stem Cell Res Ther; 2018 Sep; 9(1):235. PubMed ID: 30217223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy.
    Gao LR; Wang ZG; Zhu ZM; Fei YX; He S; Tian HT; Zhang NK; Chen Y; Xu HT; Yang Y
    Am J Cardiol; 2006 Sep; 98(5):597-602. PubMed ID: 16923443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year follow-up of transcoronary sinus administration of autologous bone marrow in patients with chronic refractory angina.
    Vicario J; Campo C; Piva J; Faccio F; Gerardo L; Becker C; Ortega H; Pierini A; Lofeudo C; Novero R; Baliño NP; Monti A; Benech R; Dallo M; Pfeiffer H
    Cardiovasc Revasc Med; 2005; 6(3):99-107. PubMed ID: 16275605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia.
    Beeres SL; Lamb HJ; Roes SD; Holman ER; Kaandorp TA; Fibbe WE; de Roos A; van der Wall EE; Schalij MJ; Bax JJ; Atsma DE
    J Magn Reson Imaging; 2008 May; 27(5):992-7. PubMed ID: 18425845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina.
    Tuma J; Fernández-Viña R; Carrasco A; Castillo J; Cruz C; Carrillo A; Ercilla J; Yarleque C; Cunza J; Henry TD; Patel AN
    J Transl Med; 2011 Oct; 9():183. PubMed ID: 22029669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of trans-endocardial delivery of bone marrow-derived CD133+ cells on angina and quality of life in patients with refractory angina: A sub-analysis of the REGENT-VSEL trial.
    Jadczyk T; Ciosek J; Michalewska-Wludarczyk A; Szot W; Parma Z; Ochala B; Markiewicz M; Rychlik W; Kostkiewicz M; Gruszczynska K; Blach A; Dzierzak-Mietla M; Rzeszutko L; Partyka L; Zasada W; Smolka G; Pawlowski T; Jedrzejek M; Starek Z; Plens K; Ochala A; Tendera M; Wojakowski W
    Cardiol J; 2018; 25(4):521-529. PubMed ID: 30211929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.